Oncology pharmacist contributions to treatment with oral anticancer agents in a Japanese community pharmacy setting-Reference-Cited by-同舟云学术

Oncology pharmacist contributions to treatment with oral anticancer agents in a Japanese community pharmacy setting

Published:2018-10-11 Issue:6 Volume:151 Page:377-382
ISSN:1715-1635
Container-title:Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
language:en
Short-container-title:Can Pharm J

Author:

Yokoyama Satoshi¹²³⁴,Yajima Satoko¹²³⁴,Shimauchi Akari¹²³⁴,Sakai Chihiro¹²³⁴,Yamashita Shuji¹²³⁴,Noguchi Yoshihiro¹²³⁴^ORCID,Ino Yoko¹²³⁴,Iguchi Kazuhiro¹²³⁴,Teramachi Hitomi¹²³⁴

Affiliation:

1. Gifu Pharmaceutical University Pharmacy (Yokoyama, Sakai, Yamashita, Noguchi, Ino, Iguchi, Teramachi)

2. Laboratory of Community Pharmacy (Yokoyama, Yajima, Shimauchi, Sakai, Ino, Iguchi), Gifu Pharmaceutical University, Gifu, Japan

3. Laboratory of Pharmacy Practice and Social Science (Yamashita), Gifu Pharmaceutical University, Gifu, Japan

4. Laboratory of Clinical Pharmacy (Noguchi, Teramachi), Gifu Pharmaceutical University, Gifu, Japan

Publisher

SAGE Publications

Subject

Pharmaceutical Science,Pharmacy

Link

http://journals.sagepub.com/doi/pdf/10.1177/1715163518802865

Reference16 articles.

1. A review of relative dose intensity and survival in patients with metastatic solid tumors

2. Oral chemotherapy safety practices at US cancer centres: questionnaire survey

3. Physician–pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice

4. The need for community pharmacists in oncology outpatient care: a systematic review

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Forty-three Years of Dedicated Efforts in Advancing Pharmacist Expertise: Aspiring to Become a Pharmacist and Cultivate Pharmacists Proficient in Recommending Prescription Medicines to Doctors;YAKUGAKU ZASSHI;2024-03-01

2. Development of evidence-based indicators for the detection of drug-related problems among ovarian cancer patients;Frontiers in Pharmacology;2023-06-30

3. Telepharmacy in oncology care: A scoping review;Journal of Telemedicine and Telecare;2020-12-30